External pharmaceutical composition as well as use method and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for external application of drugs and compositions, applied in the field of medicine, can solve the problems of dry wound, unsustainable effect, wound infection, etc., and achieve the effects of convenient and simple use, prevention of wound infection, and rapid curative effect.
Inactive Publication Date: 2012-04-11
崔双领
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Among the above-mentioned medicines for external use, calamine lotion can only slightly relieve itching, and cannot completely cure the disease at all; lezosin rivanol solution has certain anti-inflammatory and sterilizing effects, and is mainly used for suppurative infectious skin diseases, but because it is water The effect is not long-lasting, and the effect is not ideal. Using only 0.1% rivanol solution to soak gauze strips can also be used for dressing changes on surgical infected wounds; prickly heat powder can only play an antipruritic effect, and cannot really cure prickly heat. Boil; Yunnan Baiyao is a well-known external medicine with a long history of treating bruises, knife wounds and other traumatic injuries, but it is easy to cause wound infection, and the effect is not satisfactory after long-term observation; burn ointment is used for burns and skin Extensive abrasions, but it does not stop the oozing quickly and makes the wound dry and scab; other ointments are also unsatisfactory
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0019] Embodiment 1 calamine-rivanol powder
[0020] Get 1000g of calamine powder and 3g of rivanol, mix well and then bottle it for later use.
[0021] The method of use of this product is:
[0022] (1) For acute eczema and neonatal impetigo:
[0023] For common lesions or those with serious lesions, there is no need to wash them, and the powder can be directly sprinkled on the local area. After the oozing stops, the powder can be made into a paste with distilled water for injection and applied to the affected area;
[0024] (2) For large and small skin abrasions, skin I° and superficial II° burns:
[0025] The wound must be debrided, the blisters removed, and then the powder is evenly sprinkled on the wound without bandaging. After the exudation stops, change it into a paste and rub it.
Embodiment 2
[0026] Embodiment 2 calamine-rivanol ointment
[0027] Get 990g calamine powder and 4g rivanol, add 2000g simple cream and mix evenly and bottle for subsequent use.
[0028] The method of use of this product is:
[0029] After the wound is cleaned, apply the ointment evenly without bandaging.
Embodiment 3
[0030] Embodiment 3 calamine-rivanol powder
[0031] Get 1000g of calamine powder and 4g of rivanol, mix well and bottle for later use.
[0032] Using method is the same as embodiment 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides an external pharmaceutical composition as well as a use method and application thereof. The external pharmaceutical composition consists of the following components in parts by weight: 1-10 parts of rivanol and 900-1100 parts of calamine powder, preferably 3-4 parts of rivanol and 990-1010 parts of calamine powder. In the invention, pure cream, vanishing cream or vaseline can be added into the pharmaceutical composition to prepare into paste. The external pharmaceutical composition provided by the invention can be used for treating acute eczema, neonate impetigo herpetifomis, large or small area of abrasion of skin, I-degree and superficial II-degree burns and scalds of skin and other skin problems, has the unique advantages of simple use method, rapid curative effect and 100% cure rate, is economic and cost-effective, and has no stimulus to injured surface. After the pharmaceutical composition is applied to the injured surface, no pain and other adverse effects occur to patients.
Description
technical field [0001] The invention belongs to the field of medicine, in particular to external medicine for skin diseases, in particular to a pharmaceutical composition for external use and its use method and application. Background technique [0002] At present, the external medicines for treating infectious skin diseases, allergic skin diseases, bullous skin diseases, skin abrasions, burns, bedsores and other skin problems mainly include calamine lotion, levasin rivanol solution, prickly heat powder , Yunnan Baiyao, burn ointment, erythromycin ointment, Bactobang cream, zinc oxide cream, urea cream, etc. Among the above-mentioned medicines for external use, calamine lotion can only slightly relieve itching, and cannot completely cure the disease at all; lezosin rivanol solution has certain anti-inflammatory and sterilizing effects, and is mainly used for suppurative infectious skin diseases, but because it is water The effect is not long-lasting, and the effect is not...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more